Lauren Cristina

Direttore Amministrativo presso PULMONX CORPORATION

Health Technology

Consumer Services

Profilo

Lauren Cristina is currently the Vice President-Finance & Administration at Pulmonx Corp.
She previously worked as the Director-Finance & Administration at Emphasys Medical, Inc. Ms. Cristina completed her undergraduate degree and MBA from Santa Clara University.

Posizioni attive di Lauren Cristina

Società	Posizione	Inizio
PULMONX CORPORATION	Direttore Amministrativo	01/01/2009

Tutte le posizioni attive di Lauren Cristina

Precedenti posizioni note di Lauren Cristina

Società	Posizione	Fine
Emphasys Medical, Inc. Emphasys Medical, Inc. Medical SpecialtiesHealth Technology Emphasys Medical, Inc., a medical technology company, focuses on developing and commercializing minimally invasive therapeutic devices for the treatment of patients with emphysema and other breathing disorders. It offers Zephyr Endobronchial Valve system, which is designed to block air from passing through the opening in the lung and into the chest cavity, resulting in the reduction or elimination of airflow through the leak to allow the tissue to heal. The company offers its products through distributors and dealers in Europe, Australia, Hong Kong, and Singapore. Emphasys Medical was founded in 2000 and is based in Redwood City, CA. Emphasys Medical, Inc. operates as a subsidiary of Pulmonx Corp.	Direttore Finanziario/CFO	01/03/2009

Vedi nel dettaglio l'esperienza di Lauren Cristina

Formazione di Lauren Cristina

Santa Clara University

Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Lauren Cristina

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
PULMONX CORPORATION	Health Technology

Aziende private	1
Emphasys Medical, Inc. Emphasys Medical, Inc. Medical SpecialtiesHealth Technology Emphasys Medical, Inc., a medical technology company, focuses on developing and commercializing minimally invasive therapeutic devices for the treatment of patients with emphysema and other breathing disorders. It offers Zephyr Endobronchial Valve system, which is designed to block air from passing through the opening in the lung and into the chest cavity, resulting in the reduction or elimination of airflow through the leak to allow the tissue to heal. The company offers its products through distributors and dealers in Europe, Australia, Hong Kong, and Singapore. Emphasys Medical was founded in 2000 and is based in Redwood City, CA. Emphasys Medical, Inc. operates as a subsidiary of Pulmonx Corp.	Health Technology